000290462 000__ 01421cam\a22003734a\4500
000290462 001__ 290462
000290462 005__ 20210513110220.0
000290462 008__ 040512s2004\\\\njua\\\\\b\\\\001\0\eng\\
000290462 010__ $$a  2004050384
000290462 015__ $$aGBA454970
000290462 0167_ $$a012959209$$2Uk
000290462 0167_ $$a101231472$$2DNLM
000290462 020__ $$a0691121133 (alk. paper)
000290462 0291_ $$aNLM$$b101231472
000290462 035__ $$a(OCoLC)ocm55596208
000290462 035__ $$a290462
000290462 040__ $$aDLC$$cDLC$$dYDX$$dUKM$$dNLM
000290462 042__ $$apcc
000290462 043__ $$ad------
000290462 049__ $$aISEA
000290462 05000 $$aRS122$$b.K74 2004
000290462 08200 $$a362.17/82/091724$$222
000290462 1001_ $$aKremer, Michael,$$d1964-
000290462 24510 $$aStrong medicine :$$bcreating incentives for pharmaceutical research on neglected diseases /$$cMichael Kremer and Rachel Glennerster.
000290462 260__ $$aPrinceton, NJ :$$bPrinceton University Press,$$c2004.
000290462 300__ $$axiv, 153 p. :$$bill. ;$$c25 cm.
000290462 504__ $$aIncludes bibliographical references (p. 127-143) and index.
000290462 650_0 $$aPharmacy$$xResearch$$xEconomic aspects$$zDeveloping countries.
000290462 650_0 $$aDrugs$$xResearch$$xEconomic aspects$$zDeveloping countries.
000290462 650_0 $$aVaccines$$xResearch$$xEconomic aspects$$zDeveloping countries.
000290462 7001_ $$aGlennerster, Rachel.
000290462 85200 $$bgen$$hRS122$$i.K74$$i2004
000290462 85642 $$3Contributor biographical information$$uhttp://www.loc.gov/catdir/bios/prin051/2004050384.html
000290462 85642 $$3Publisher description$$uhttp://www.loc.gov/catdir/description/prin051/2004050384.html
000290462 909CO $$ooai:library.usi.edu:290462$$pGLOBAL_SET
000290462 980__ $$aBIB
000290462 980__ $$aBOOK
000290462 994__ $$aC0$$bISE